MedTrace Logo

COMBINATION OF LATISSIMUS DORSI AND GLUTEAL STRENGTHENING IN SACROILIAC DYSFUNCTION

NCT07477717 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-17

No results posted yet for this study

Summary

The current study will try to answer the following research question:

In adults with sacroiliac joint dysfunction, what is the effect of combination LD strengthening exercises with gluteal strengthening exercises compared with gluteal strengthening exercises alone on the primary outcomes of this study (pain intensity during pressure on posterior superior iliac spine \[PSIS\] and neuropathic pain severity) and the secondary outcomes (disability, pelvic inclination, pelvic torsion, sacral inclination, GMax and LD strength)?

Participants will be devided equally into two groups:

1. Group A (Control group): will receive a gluteal strengthening exercise program.
2. Group B (Intervention group): will receive the same gluteal strengthening exercise program as group A, in addition to the LD strengthening exercise program.

Conditions

  • Sacroiliac Dysfunction

Interventions

OTHER

Gluteal strengthening exercise program

Retro Step-Up Unilateral Wall Squat Wall Press Exercise Prone Hip Extension The treatment duration will be 6 weeks at a frequency of 3 supervised sessions/week (18 sessions total).

OTHER

Gluteal strengthening combined with LD strengthening exercise program

Retro Step-Up Unilateral Wall Squat Wall Press Exercise Prone Hip Extension Conventional shoulder extension in the prone position Downward bar pulling in the seated position (LPD) following expert instruction Pull-down exercises from standing position Inverted row body weight exercises with a supinated grip and double-leg WB Modified curl-up Ipsilateral upper trunk bending The treatment duration will be 6 weeks at a frequency of 3 supervised sessions/week (18 sessions total).

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Shefaa AA Shuaib, MSc · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-08-30
Completion
2026-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07477717 on ClinicalTrials.gov